# Daewon Pharmaceuticals

Daewon Pharmaceuticals is a Corporate Investor based in Seoul, South Korea.

## Overview

- **Organization type:** Corporate Investor
- **Headquarters:** Seoul, South Korea
- **Region:** Asia
- **Address:** Seoul, South Korea
- **Founded:** 1958
- **Assets under management:** Undisclosed
- **Website:** daewonpharm.com
- **LinkedIn:** https://www.linkedin.com/company/daewon-pharmaceutical-co-ltd

## Regulatory record

- **Reports private funds:** No

## About

Daewon Pharmaceuticals was established in 1958 in South Korea. Baek Seung-ho serves as chairman and second-generation owner. His brother Baek Seung-yeol is vice chairman. Baek In-hwan, son of Baek Seung-ho, holds the roles of president and CEO. The company operates as a corporate investor in biopharmaceuticals. It maintains three production and research facilities inside South Korea. Daewon holds membership in Seoul Bio Hub for startup discovery and participates in the MIT Japan Conference. Heart to Heart Foundation serves as the associated philanthropic vehicle. No recent operational events from the last 24 months appear in available records. Team size and deployment figures remain undisclosed.

## Sectors

- Healthcare

## People

- Baek Seung-ho — Chairman
- Baek Seung-yeol — Vice Chairman
- Baek In-hwan — President and CEO
- Baek In-yeong — CEO of SD Biotechnologies

## Questions

### Who runs investment decisions at Daewon Pharmaceuticals?

Baek In-hwan serves as president and CEO. Baek Seung-ho chairs the firm as second-generation owner.

## Related profiles

- [Daesung Private Equity](https://altss.com/profile/daesung-private-equity)
- [DA Financial Advisors](https://altss.com/profile/da-financial-advisors)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/daewon-pharmaceuticals

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology